Delivery Order SPE2DB20D2104-SPE2DB25F2024
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a contract value of $1,780.51. This competitively awarded, firm fixed price delivery order is set to be completed by July 28, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and is issued as a child order under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,451.98 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $2,167.73. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Brilinta 60 mg tablets (60-count) under a firm fixed price contract with a ceiling value of $5,888.96 and an ultimate completion date of July 21, 2025. This is a competitive award with no set-aside designation, issued as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $1,847.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Brilinta 60 mg tablets (60-count). The contract, which is not set-aside and competitively awarded, is scheduled for completion by July 21, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,922.04 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is being performed at the contractor's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $2,496.78 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price contract reflects a non-set-aside procurement and represents a routine pharmaceutical supply transaction under the company's existing federal contracting relationships. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,890.12 to AmerisourceBergen Drug Corp for supply of Brilinta 60 mg tablets (60-count units) with an ultimate completion date of July 30, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader federal pharmaceutical supply framework. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a contract ceiling value of $3,541.70. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25F2024Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Brilinta 90 mg tablets (60-count units) valued at $3,168.70 under a firm fixed price contract. This delivery order was competitively awarded without set-aside designation and is set to be completed by August 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999.999 billion through December 2026. As a major pharmaceutical distributor serving the federal government, AmerisourceBergen Drug Corp supplies brand-name and generic medications, vaccines, and specialized medical commodities to support military healthcare programs and other federal health systems worldwide. The company's position as a prime vendor reflects its capability to meet federal procurement requirements across multiple therapeutic domains in support of Defense Health Agency and other government healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/5/25 |